Clinical Trials
3 trialsNCT06765590 2026-03-09
Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase NA Recruiting
NCT01369433 2020-09-01
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
AVEO Pharmaceuticals, Inc.
Phase NA Terminated
NCT02066103 2018-04-20
BROADWAY
Mercator MedSystems, Inc.
Phase NA Completed